Literature DB >> 15083380

Aromatase and endometriosis.

Serdar E Bulun1, Zongjuan Fang, Gonca Imir, Bilgin Gurates, Mitsutoshi Tamura, Bertan Yilmaz, David Langoi, Sanober Amin, Sijun Yang, Santanu Deb.   

Abstract

Aromatase p450 (p450arom) is the key enzyme for biosynthesis of estrogen, which is an essential hormone for the establishment and growth of endometriosis. There is no detectable aromatase enzyme activity in normal endometrium; therefore, estrogen is not locally produced in endometrium. Endometriosis tissue, however, contains very high levels of aromatase enzyme, which leads to production of significant quantities of estrogen. Moreover, one of the best-known mediators of inflammation and pain, prostaglandin E (2), strikingly induces aromatase enzyme activity and formation of local estrogen in this tissue. Additionally, estrogen itself stimulates cyclo-oxygenase-2 and therefore increases the formation of prostaglandin E (2) in endometriosis. We were able to target this positive feedback cycle in endometriosis using aromatase inhibitors. In fact, pilot trials showed that aromatase inhibitors could decrease pelvic pain associated with endometriosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15083380     DOI: 10.1055/s-2004-823026

Source DB:  PubMed          Journal:  Semin Reprod Med        ISSN: 1526-4564            Impact factor:   1.303


  21 in total

Review 1.  The role of aromatase inhibitors in ameliorating deleterious effects of ovarian stimulation on outcome of infertility treatment.

Authors:  Mohamed F M Mitwally; Robert F Casper; Michael P Diamond
Journal:  Reprod Biol Endocrinol       Date:  2005-10-04       Impact factor: 5.211

2.  Aromatase inhibitor regulates let-7 expression and let-7f-induced cell migration in endometrial cells from women with endometriosis.

Authors:  SiHyun Cho; Levent Mutlu; Yuping Zhou; Hugh S Taylor
Journal:  Fertil Steril       Date:  2016-06-16       Impact factor: 7.329

Review 3.  Aromatase inhibitors for the treatment of endometriosis.

Authors:  Mary Ellen Pavone; Serdar E Bulun
Journal:  Fertil Steril       Date:  2012-09-19       Impact factor: 7.329

4.  Aromatase inhibitor treatment limits progression of peritoneal endometriosis in baboons.

Authors:  David Langoi; Mary Ellen Pavone; Bilgin Gurates; Daniel Chai; Asgerally Fazleabas; Serdar E Bulun
Journal:  Fertil Steril       Date:  2012-12-17       Impact factor: 7.329

5.  Roles of hormone replacement therapy and iron in proliferation of breast epithelial cells with different estrogen and progesterone receptor status.

Authors:  Jisen Dai; Jinlong Jian; Maarten Bosland; Krystyna Frenkel; Güenther Bernhardt; Xi Huang
Journal:  Breast       Date:  2007-10-24       Impact factor: 4.380

6.  Inflammation in the uterus induces phosphorylated extracellular signal-regulated kinase and substance P immunoreactivity in dorsal root ganglia neurons innervating both uterus and colon in rats.

Authors:  Jichang Li; Paul Micevych; John McDonald; Andrea Rapkin; Victor Chaban
Journal:  J Neurosci Res       Date:  2008-09       Impact factor: 4.164

7.  Ablation of leptin signaling disrupts the establishment, development, and maintenance of endometriosis-like lesions in a murine model.

Authors:  Aaron K Styer; Brian T Sullivan; Mark Puder; Danielle Arsenault; John C Petrozza; Takehiro Serikawa; Sung Chang; Tayyaba Hasan; Ruben R Gonzalez; Bo R Rueda
Journal:  Endocrinology       Date:  2007-10-25       Impact factor: 4.736

8.  PPARγ activation inhibits growth and survival of human endometriotic cells by suppressing estrogen biosynthesis and PGE2 signaling.

Authors:  Dan I Lebovic; Shahryar K Kavoussi; JeHoon Lee; Sakhila K Banu; Joe A Arosh
Journal:  Endocrinology       Date:  2013-09-24       Impact factor: 4.736

9.  Polymorphisms and haplotypes of the gene encoding the estrogen-metabolizing CYP19 gene in Korean women: no association with advanced-stage endometriosis.

Authors:  Sung Eun Hur; Sara Lee; Ji Young Lee; Hye-Sung Moon; Hyung Lae Kim; Hye Won Chung
Journal:  J Hum Genet       Date:  2007-08-09       Impact factor: 3.172

10.  Expression of oestrogen receptors, ERalpha, ERbeta, and ERbeta variants, in endometrial cancers and evidence that prostaglandin F may play a role in regulating expression of ERalpha.

Authors:  Frances Collins; Sheila MacPherson; Pamela Brown; Vincent Bombail; Alistair R W Williams; Richard A Anderson; Henry N Jabbour; Philippa T K Saunders
Journal:  BMC Cancer       Date:  2009-09-16       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.